{"gene":"BLNK","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":1998,"finding":"BLNK (B cell linker protein) was identified as a novel adaptor protein that interfaces the BCR-associated Syk tyrosine kinase with PLCγ, Vav guanine nucleotide exchange factor, and Grb2 and Nck adapter proteins. Tyrosine phosphorylation of BLNK by Syk provides docking sites for these SH2-containing effector molecules.","method":"Biochemical identification, Co-immunoprecipitation, tyrosine phosphorylation assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — foundational discovery replicated across multiple labs, reciprocal Co-IP with multiple binding partners","pmids":["9697839"],"is_preprint":false},{"year":1998,"finding":"SLP-65/BLNK is a BCR signaling component that becomes tyrosine-phosphorylated upon BCR stimulation only when the BCR is expressed on the cell surface, and forms a signaling complex with Grb2 and Vav; phosphorylation requires BCR expression and is downstream of the BCR signaling subunit.","method":"Biochemical characterization, Co-immunoprecipitation, pervanadate stimulation assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — independently replicated, multiple orthogonal methods","pmids":["9705962"],"is_preprint":false},{"year":1999,"finding":"BLNK is required for BCR-induced PLCγ2 activation and JNK activation in B cells. The BCR-induced PLCγ2 activation (but not JNK activation) was restored by membrane-targeted PLCγ2 in BLNK-deficient B cells, indicating BLNK modulates PLCγ2 localization. JNK activation requires both Rac1 and PLCγ2, placing BLNK upstream of the Rac1-JNK pathway.","method":"Genetic reconstitution in BLNK-deficient DT40 B cells, membrane-targeted PLCγ2 rescue experiments","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1-2 — epistasis via reconstitution in BLNK-deficient cells with multiple pathway readouts","pmids":["10023776"],"is_preprint":false},{"year":1999,"finding":"BLNK is required in vivo for the pro-B to pre-B cell transition; BLNK-deficient mice are blocked at the B220+CD43+ progenitor B to B220+CD43- precursor B cell stage. BLNK links BCR-activated Syk kinase to the phosphoinositide and mitogen-activated kinase pathways.","method":"BLNK knockout mouse generation, flow cytometry of bone marrow B cell populations","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, independently replicated","pmids":["10583957"],"is_preprint":false},{"year":1999,"finding":"Loss-of-function splice defect in human BLNK causes a block at the pro-B to pre-B cell transition, establishing an essential non-redundant role of BLNK in human B cell development.","method":"Patient genetic analysis, bone marrow immunophenotyping","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — human loss-of-function with defined cellular phenotype, confirmed in multiple subsequent patients","pmids":["10583958"],"is_preprint":false},{"year":1999,"finding":"BLNK was identified as a major SH2 domain-binding protein of Bruton's tyrosine kinase (Btk); the interaction of BLNK with the SH2 domain of Btk contributes to complete tyrosine phosphorylation of PLCγ in BCR signaling.","method":"Protein purification, Co-immunoprecipitation, in vitro binding assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — reciprocal pulldown and functional consequence demonstrated","pmids":["10498607"],"is_preprint":false},{"year":1999,"finding":"The N-terminal SH2 domain of PLCγ2 mediates association with BLNK, and this interaction is required for inositol 1,4,5-trisphosphate generation upon BCR engagement; membrane-associated PLCγ2 with SH2(N) mutation still required BCR-CD16 co-ligation for activation, indicating BLNK directs PLCγ2 into proximity of the BCR signaling complex.","method":"Reconstitution in PLCγ2-deficient DT40 cells with SH2 domain mutants, IP3 generation assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis plus functional reconstitution in defined-deficient cells","pmids":["10438904"],"is_preprint":false},{"year":2001,"finding":"BLNK mediates Syk-dependent Btk activation: BLNK allows Syk to phosphorylate Btk on tyrosine 551, enhancing Btk kinase activity. This requires the Btk-SH2 domain interaction with BLNK, and BCR-induced Btk phosphorylation and activation are significantly reduced in BLNK-deficient B cells.","method":"Reconstitution cell system, co-expression assays, phosphorylation analysis in BLNK-deficient cells, kinase activity assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution plus mutagenesis plus BLNK-deficient cell validation","pmids":["11226282"],"is_preprint":false},{"year":2001,"finding":"BLNK associates directly with the BCR signaling subunit Igα/Igβ heterodimer; this interaction is mediated by the SH2 domain of SLP-65 and the phosphorylated Igα tyrosine 204, which is located outside the ITAM, providing a mechanism for SLP-65 recruitment to the plasma membrane.","method":"Co-immunoprecipitation, direct binding assays with phospho-peptides, mutational analysis of Igα","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — direct biochemical interaction with defined binding sites confirmed by mutation","pmids":["11449366"],"is_preprint":false},{"year":2001,"finding":"BLNK is required for BCR-activated NF-κB activation, cell cycle entry (cyclin D2, CDK4 expression), and Bcl-xL upregulation. BLNK-deficient B cells show intact Akt and MAPK activation but impaired PLCγ2 and NF-κB activation, suggesting BLNK orchestrates a Btk-PLCγ2 signaling axis that regulates NF-κB.","method":"BLNK-knockout B cells, proliferation assays, Western blotting for cell cycle proteins and NF-κB pathway components","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple orthogonal pathway readouts","pmids":["11274146"],"is_preprint":false},{"year":2002,"finding":"The non-ITAM tyrosines Y176 and Y204 of Igα are required for BLNK-dependent signaling pathways; BLNK binds directly to phospho-Y204 of Igα. Fusing BLNK to mutated Igα reconstituted downstream signaling, and BCR ligation induces Y204 phosphorylation and BLNK recruitment.","method":"Chimeric receptor reconstitution, mutational analysis of Igα, direct binding assays, Co-immunoprecipitation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution with chimeric receptors plus mutagenesis and direct binding confirmation","pmids":["11909947"],"is_preprint":false},{"year":2002,"finding":"Phosphorylation of five tyrosine residues within human BLNK nucleates distinct signaling effectors following BCR activation. Multiple tyrosine phosphorylations amplify PLCγ-mediated signaling and support 'cis'-mediated interaction between distinct signaling effectors within a large macromolecular complex.","method":"Mutagenesis of BLNK tyrosines, reconstitution in BLNK-deficient cells, biochemical analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with functional readouts","pmids":["12456653"],"is_preprint":false},{"year":2002,"finding":"BLNK is a direct transcriptional target of Pax5 (BSAP); Pax5-dependent activation of BLNK expression is required for coupling Syk to downstream effector pathways during the pro-B to pre-B cell transition triggered by pre-BCR signaling.","method":"Genetic reconstitution of BLNK in Pax5-/- pro-B cells, inducible BLNK-ER fusion protein, gene expression analysis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — epistasis via reconstitution with defined genetic models","pmids":["12387741"],"is_preprint":false},{"year":2002,"finding":"SLP-65 (BLNK) acts as a tumor suppressor in pre-B cells: SLP-65-deficient pre-B cells show enhanced IL-7-dependent proliferative capacity and high incidence of pre-B lymphoma; reintroduction of SLP-65 led to pre-BCR downregulation and enhanced differentiation.","method":"SLP-65-/- mouse analysis, ex vivo proliferation assays, retroviral reconstitution","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — clean KO plus reconstitution with defined functional phenotypes","pmids":["12436112"],"is_preprint":false},{"year":2001,"finding":"BASH/BLNK SH2 domain interacts with hematopoietic progenitor kinase 1 (HPK1) upon BCR ligation through binding to phospho-Tyr379 of HPK1 (phosphorylated by Syk). This interaction activates HPK1 catalytically and subsequently activates IKKβ, defining a BCR signaling pathway from BASH to HPK1 to NF-κB.","method":"Co-immunoprecipitation, kinase activation assays, BASH- and Syk-deficient B cell analysis, mutational analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, deficient cell validation, phospho-site mutagenesis","pmids":["11514608"],"is_preprint":false},{"year":2003,"finding":"BLNK and Grb2 cooperate to localize Vav3 into membrane rafts, which is required for efficient Rac1 activation upon BCR stimulation. Loss of either Grb2 or BLNK reduces Vav3 translocation to rafts; raft-targeted Vav3 restores defective Rac1 activation in Grb2- or BLNK-deficient cells.","method":"Membrane raft fractionation, epistasis via raft-targeted Vav3 rescue in BLNK/Grb2-deficient B cells","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — epistasis rescue experiment with multiple genetic models","pmids":["12818159"],"is_preprint":false},{"year":2005,"finding":"A leucine zipper motif in the N-terminus of SLP-65 is responsible for its membrane association. Mutations in the N-terminus abolished SLP-65 membrane localization and activity; replacement with a myristoylation signal restored both. The N-terminus is a transferable autonomous domain that confers specific localization.","method":"Mutational analysis of SLP-65 N-terminus, GFP fusion localization, functional reconstitution in SLP-65-deficient cells","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis with localization and functional readouts, domain transfer experiment","pmids":["15654340"],"is_preprint":false},{"year":2007,"finding":"The C-terminal SH2 domain of SLP-65 controls efficient tyrosine phosphorylation by Syk, plasma membrane recruitment, and downstream signaling to NFAT. A kinase-independent adaptor function of Syk is required to link phosphorylated SLP-65 to Ca2+ mobilization, placing Syk both upstream and downstream of SLP-65.","method":"Mutational analysis in DT40 B cells; reconstitution of SLP-65 in SLP-76-deficient T cells; genetic epistasis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — two genetic reconstitution systems with orthogonal readouts","pmids":["17681949"],"is_preprint":false},{"year":2008,"finding":"BLNK suppresses pre-B cell leukemogenesis through direct physical binding to JAK3, inhibiting JAK3/STAT5 signaling and autocrine IL-7-driven proliferation. BLNK deficiency leads to constitutive JAK3/STAT5 activation; exogenous BLNK inhibited JAK3 activity dependent on the BLNK-JAK3 interaction.","method":"Co-immunoprecipitation, JAK3 kinase assays, JAK3 inhibitor treatment, STAT5-CA transgenic mouse, retroviral BLNK reconstitution in leukemia cells","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — direct binding demonstrated plus functional reconstitution with multiple readouts","pmids":["19047679"],"is_preprint":false},{"year":2008,"finding":"SLP-65 counteracts PKB activation and promotes Foxo3a and Foxo1 activity in pre-B cells, thereby regulating light chain recombination. SLP-65-dependent signaling is linked to the PI(3)K-PKB-Foxo pathway, wherein PKB suppresses light chain recombination by phosphorylating Foxo proteins.","method":"Reconstitution of SLP-65 in deficient cells, epistasis with PKB inhibitors, Foxo reporter assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — pathway epistasis with reconstitution and defined molecular intermediaries","pmids":["18488031"],"is_preprint":false},{"year":2009,"finding":"The SLP-65/CIN85 complex is constitutively (stimulation-independently) associated in resting B cells. This pre-formed complex is required for SLP-65 phosphorylation and inducible plasma membrane translocation. In the absence of a SLP-65/CIN85 complex, BCR-induced Ca2+ and NF-κB responses are abrogated.","method":"Quantitative mass spectrometry interactome, live cell imaging (FRAP), Co-immunoprecipitation, CIN85-deficient cell analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — MS-quantified interactome plus functional validation in deficient cells plus live imaging","pmids":["21822214"],"is_preprint":false},{"year":2009,"finding":"Mass spectrometry-based phosphoproteomics of SLP-65 revealed differential and dynamic engagement of numerous phospho-acceptor sites, including constitutive and BCR-induced phosphorylations. Serine 170 phosphorylation of SLP-65 acts as a BCR-distal checkpoint controlling some but not all B cell responses.","method":"Mass spectrometric phosphorylation mapping on DT40 cells, mutational analysis of phospho-sites with functional readouts","journal":"Molecular & cellular proteomics : MCP","confidence":"High","confidence_rationale":"Tier 1-2 — MS-based discovery with mutagenesis validation","pmids":["19372136"],"is_preprint":false},{"year":2009,"finding":"BLNK binds the active (GTP-bound) form of H-Ras through a 10-amino acid Ras-binding domain. This interaction, facilitated by BCR cross-linking, is required for sustained ERK activation and BCR capping. The Ras-binding domain is necessary for restoring ERK activation and anti-apoptotic signaling in BLNK-deficient B cells.","method":"Pulldown assays, mutational analysis of BLNK Ras-binding domain, reconstitution in BLNK-deficient cells, BCR capping assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct binding domain mapped plus functional reconstitution","pmids":["19218240"],"is_preprint":false},{"year":2011,"finding":"CMTM7, a tetra-spanning membrane protein, co-localizes with sIgM at the plasma membrane and links sIgM to BLNK. CMTM7 knockdown impairs BLNK-Syk interaction and BLNK phosphorylation. CMTM7 is constitutively associated with sIgM, and this is required for BLNK recruitment to sIgM.","method":"RNAi knockdown, Co-immunoprecipitation, mutational analysis of CMTM7 domains, functional rescue experiments","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — RNAi plus domain mutant rescue plus Co-IP","pmids":["22363743"],"is_preprint":false},{"year":2012,"finding":"HPK1 phosphorylates BLNK at threonine 152, which mediates BLNK/14-3-3 binding. Thr152-phosphorylated BLNK is then ubiquitinated at lysines 37, 38, and 42, leading to BLNK degradation and attenuation of MAPK and IKK activation during BCR signaling (negative feedback).","method":"Kinase assays, site-directed mutagenesis, ubiquitination assays, HPK1-deficient B cell analysis, Co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — kinase assay plus mutagenesis of phospho-acceptor and ubiquitin sites plus deficient cell validation","pmids":["22334673"],"is_preprint":false},{"year":2013,"finding":"The C2 domain of PLCγ2 docks in a Ca2+-regulated manner to a distinct phosphotyrosine of SLP-65, providing feed-forward signal amplification: early Ca2+ flux promotes anchoring of the PLCγ2 C2 domain to phospho-SLP65, and declining Ca2+ terminates PLCγ2 activation despite sustained SLP65 phosphorylation.","method":"Mutational analysis of PLCγ2 C2 domain, Ca2+-regulated binding assays, Co-immunoprecipitation, functional reconstitution","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis plus Ca2+-regulated binding plus functional reconstitution","pmids":["24166973"],"is_preprint":false},{"year":2014,"finding":"SLP-65 assembles at intracellular vesicular compartments in resting B cells through an ~50 amino acid N-terminal module that binds non-charged lipid components of cellular membranes in a structurally ordered manner (disordered in solution). Pre-formed vesicular signaling scaffolds are required for BCR activation.","method":"NMR spectroscopy of SLP-65 N-terminus with membrane lipids, live cell imaging, fractionation, mutational analysis","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1 — NMR structural characterization plus live imaging plus functional validation","pmids":["25140054"],"is_preprint":false},{"year":2020,"finding":"The 14-3-3/BLNK interaction follows a gatekeeper model: HPK1-mediated phosphorylation of Thr152 (pT152) anchors BLNK to 14-3-3, and additional phosphorylation of Ser285 by AKT further improves affinity. Crystal structure of BLNKpT152 peptide bound to 14-3-3σ was solved.","method":"Fluorescent polarization, isothermal titration calorimetry, X-ray crystallography of BLNK peptide/14-3-3σ complex","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus biophysical characterization of the interaction","pmids":["33176192"],"is_preprint":false},{"year":2024,"finding":"SLP65 and CIN85 form phase-separated condensates at intracellular vesicles in resting B cells via multivalent interactions (6 proline-rich motifs of SLP65 engaging 3 SH3 domains of CIN85, establishing 18 individual SH3-PRM interactions). Thermodynamic characterization of individual PRM/SH3 interactions allowed modeling of phase-separation behavior, and a previously unknown intramolecular interaction within the system was discovered.","method":"Biophysical measurement of individual dissociation constants, LASSI computational modeling, phase-separation assays with designer constructs","journal":"PNAS nexus","confidence":"High","confidence_rationale":"Tier 1-2 — quantitative biophysical characterization of individual interactions plus validated computational modeling","pmids":["38463037"],"is_preprint":false},{"year":2024,"finding":"In macrophages, CLR (C-type lectin receptor)-activated Syk phosphorylates BLNK, which then associates with c-Cbl and competitively inhibits the Fyn-c-Cbl interaction, disrupting c-Cbl-associated F-actin assembly and podosome ring formation, thereby impeding macrophage migration. BLNK deficiency in monocytes enhances migration and resistance to Candida albicans infection.","method":"Co-immunoprecipitation, monocyte-specific BLNK conditional KO mice, podosome assays, migration assays, murine infection model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined molecular mechanism plus in vivo infection model","pmids":["39413134"],"is_preprint":false},{"year":2022,"finding":"In breast cancer cells, BLNK promotes anoikis (detachment-induced cell death) by activating p38 MAP kinase. ErbB2 blocks BLNK upregulation upon ECM detachment by reducing IRF6 transcription factor levels. Bortezomib upregulates IRF6 and BLNK, inhibiting 3D tumor growth in a BLNK-dependent manner.","method":"siRNA knockdown, anoikis assays, p38 kinase pathway analysis, IRF6 manipulation, xenograft tumor assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 — KD with defined pathway placement, but in non-lymphoid context without full reconstitution","pmids":["35933456"],"is_preprint":false},{"year":2022,"finding":"BLNK interacts with Met receptor in non-small cell lung cancer cells, positively regulates Met signaling, and modulates ligand-dependent trafficking of Met. The BLNK-GRB2 constitutive interaction is increased in the presence of active Met, and Met-GRB2 interaction is increased in the presence of BLNK.","method":"Mammalian Membrane Two-Hybrid (MaMTH) interactome mapping, Co-immunoprecipitation, siRNA knockdown, trafficking and functional assays","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP pulldown plus functional KD but single study in non-lymphoid context","pmids":["36388990"],"is_preprint":false},{"year":2017,"finding":"In CLL cells, BLNK participates in a CK2-CD5-BLNK-STAT3 complex that mediates constitutive serine 727 phosphorylation of STAT3. BLNK and CD5 are both required for STAT3 phosphorylation; siRNA knockdown of CD5 or BLNK significantly reduced pSTAT3 levels.","method":"Mass spectrometry identification of CK2 as STAT3 co-immunoprecipitant, in vitro CK2 kinase assay on STAT3, siRNA knockdown, fractionation studies, confocal microscopy","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2-3 — in vitro kinase assay plus Co-IP plus siRNA, but single lab and unusual cellular context","pmids":["28130399"],"is_preprint":false},{"year":2000,"finding":"Neither SLP-76 nor LAT alone is sufficient to restore signaling deficits in BLNK-deficient B cells, but co-expression of SLP-76 and LAT together restores BCR-inducible calcium responses and activation of all three MAPK families, demonstrating functional complementation.","method":"Reconstitution of SLP-76 and LAT in BLNK-deficient B cells, Ca2+ flux assays, MAPK activation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — epistasis via genetic reconstitution with multiple functional readouts","pmids":["10934198"],"is_preprint":false},{"year":2006,"finding":"SLP-65 promotes B cell differentiation via a BASH-nPKC-Raf-1 pathway that induces kappa light chain gene rearrangement. Pre-BCR signaling through BASH activates novel PKC (nPKC) and MEK but not Ras; PKCη translocates to the plasma membrane upon BASH reconstitution.","method":"BASH-deficient pre-B cell lines, specific kinase inhibitors, retroviral transduction of active PKC/Raf-1, tamoxifen-inducible BASH reconstitution","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — epistasis with inhibitors and genetic reconstitution identifying a Ras-independent signaling branch","pmids":["16794253"],"is_preprint":false},{"year":2022,"finding":"SLP65 activates the small GTPase RHOA, which activates PTEN by enabling its translocation to the plasma membrane, thereby counteracting PI3K signaling in pre-B cells. Conditional RhoA-deficient mice show a complete block in early B cell development and fail to activate Ig gene rearrangement.","method":"Conditional RhoA knockout mice, PTEN membrane translocation assays, RhoA/Foxo1 reconstitution in RhoA-deficient cells, flow cytometric phenotyping","journal":"Frontiers in immunology","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with mechanistic reconstitution placing SLP65 upstream of RHOA-PTEN-PI3K axis","pmids":["35371049"],"is_preprint":false}],"current_model":"BLNK/SLP-65 is a central scaffolding adaptor protein that is recruited to the BCR complex via direct binding of its SH2 domain to phospho-Tyr204 of Igα (facilitated by CMTM7), is phosphorylated on multiple tyrosines by Syk, and then nucleates a large signaling complex—preassembled as a phase-separated condensate with CIN85 at intracellular vesicles—that coordinates PLCγ2 activation (via SH2 and Ca2+-regulated C2 domain interactions), Btk activation (via Syk-mediated Tyr551 phosphorylation scaffolded by BLNK), Vav/Rac1 membrane raft targeting, H-Ras-ERK signaling, NF-κB activation, and Foxo-dependent light chain recombination, while being subject to negative feedback through HPK1-mediated Thr152 phosphorylation leading to 14-3-3 binding and ubiquitin-proteasomal degradation, and acting as a tumor suppressor in pre-B cells by directly inhibiting JAK3 and linking pre-BCR signals to RHOA-PTEN-mediated PI3K downregulation."},"narrative":{"teleology":[{"year":1998,"claim":"The identification of BLNK as a Syk substrate that docks PLCγ, Vav, Grb2, and Nck established that a single adaptor protein bridges BCR-proximal kinase signaling to multiple effector pathways, resolving how Syk communicates with diverse downstream targets.","evidence":"Biochemical purification, reciprocal Co-IP, and tyrosine phosphorylation mapping in B cell lines","pmids":["9697839","9705962"],"confidence":"High","gaps":["Specific phosphotyrosine–effector assignments not yet mapped","In vivo requirement not yet tested"]},{"year":1999,"claim":"Genetic studies in BLNK-knockout mice and a human patient with BLNK splice-site mutation demonstrated that BLNK is non-redundantly required for the pro-B to pre-B cell transition, establishing it as essential for early B cell development and a cause of human agammaglobulinemia.","evidence":"BLNK knockout mouse phenotyping by flow cytometry; human patient genetic and immunophenotypic analysis","pmids":["10583957","10583958"],"confidence":"High","gaps":["Downstream signaling events mediating the developmental block not yet dissected","Whether BLNK has roles beyond early B cell development unknown"]},{"year":1999,"claim":"Reconstitution experiments in BLNK-deficient DT40 cells showed that BLNK controls PLCγ2 activation by directing its membrane localization and that BLNK scaffolds the Btk–PLCγ2 axis, resolving the mechanism by which the BCR activates phospholipase C.","evidence":"Membrane-targeted PLCγ2 rescue in BLNK-deficient DT40 cells; PLCγ2 SH2 domain mutagenesis; Btk-SH2/BLNK binding assays","pmids":["10023776","10438904","10498607"],"confidence":"High","gaps":["Whether PLCγ2 engagement involves additional regulatory domains beyond SH2 not yet known","Stoichiometry of the BLNK–Btk–PLCγ2 complex undefined"]},{"year":2001,"claim":"Mapping of the BLNK–Igα interaction to phospho-Tyr204 (a non-ITAM tyrosine) via the BLNK SH2 domain resolved how BLNK is recruited to the BCR complex, establishing a mechanism distinct from classical ITAM-dependent signaling.","evidence":"Direct binding assays with phospho-peptides, Igα mutagenesis, chimeric receptor reconstitution","pmids":["11449366","11909947"],"confidence":"High","gaps":["How Tyr204 phosphorylation is itself regulated was unknown","Whether additional BCR subunit contacts contribute to BLNK recruitment not tested"]},{"year":2001,"claim":"Demonstration that BLNK scaffolds Syk-dependent phosphorylation of Btk at Tyr551 and that BLNK is required for NF-κB activation and cell cycle entry clarified that BLNK integrates BCR signals for both Ca²⁺ and NF-κB/survival pathways.","evidence":"Reconstitution/kinase assays in BLNK-deficient cells; NF-κB, cyclin D2, and Bcl-xL readouts in BLNK-KO B cells","pmids":["11226282","11274146","11514608"],"confidence":"High","gaps":["Precise mechanism linking BLNK to IKK activation via HPK1 not fully resolved","Whether BLNK-independent NF-κB pathways compensate in vivo unknown"]},{"year":2002,"claim":"Systematic tyrosine mutagenesis of five BLNK phosphosites revealed that distinct phosphotyrosines nucleate different effector combinations, establishing a combinatorial phosphorylation code that amplifies PLCγ signaling through cis-interactions within a macromolecular complex.","evidence":"Individual and combinatorial Tyr-to-Phe mutagenesis with functional reconstitution in BLNK-deficient cells","pmids":["12456653"],"confidence":"High","gaps":["Which kinase phosphorylates each individual tyrosine not fully determined","Temporal order of phosphorylation events unresolved"]},{"year":2002,"claim":"Discovery that SLP-65 deficiency leads to pre-B cell lymphoma and that its reintroduction restores differentiation established BLNK as a tumor suppressor, linking its signaling scaffold function to control of pre-B cell proliferation.","evidence":"SLP-65 knockout mouse tumor incidence, ex vivo proliferation assays, retroviral reconstitution","pmids":["12436112"],"confidence":"High","gaps":["Molecular mechanism of tumor suppression not yet identified","Whether tumor suppression is cell-autonomous not fully confirmed"]},{"year":2003,"claim":"Showing that BLNK and Grb2 cooperate to relocalize Vav3 into membrane rafts for Rac1 activation clarified how BLNK couples BCR signaling to cytoskeletal and JNK pathways through spatial control of a GEF.","evidence":"Raft fractionation and raft-targeted Vav3 rescue in BLNK- and Grb2-deficient DT40 cells","pmids":["12818159"],"confidence":"High","gaps":["Whether Vav1/Vav2 are similarly regulated by BLNK not tested","In vivo relevance of raft targeting for B cell function not established"]},{"year":2005,"claim":"Identification of a leucine zipper-like N-terminal module as the autonomous membrane-targeting domain of SLP-65 resolved how this cytosolic adaptor achieves membrane association independently of BCR stimulation.","evidence":"N-terminal deletion/substitution mutagenesis with GFP localization and functional reconstitution in SLP-65-deficient cells","pmids":["15654340"],"confidence":"High","gaps":["Lipid specificity of the N-terminal module not yet defined","Whether membrane targeting occurs at plasma membrane or intracellular vesicles not distinguished"]},{"year":2008,"claim":"Identification of direct BLNK–JAK3 binding and demonstration that BLNK inhibits JAK3/STAT5 signaling provided the molecular mechanism for BLNK's tumor suppressor function, explaining how its loss leads to constitutive proliferative signaling in pre-B cells.","evidence":"Co-IP, JAK3 kinase assays, JAK3 inhibitor treatment, and retroviral BLNK reconstitution in leukemia cells","pmids":["19047679"],"confidence":"High","gaps":["Structural basis of BLNK–JAK3 inhibition unknown","Whether JAK3 inhibition is the sole tumor-suppressive mechanism not determined"]},{"year":2008,"claim":"Linking SLP-65 to the PI3K–PKB–Foxo axis showed that BLNK counteracts PKB to promote Foxo-dependent light chain recombination, connecting the scaffold's signaling role to V(D)J recombination and B cell differentiation.","evidence":"SLP-65 reconstitution in deficient pre-B cells with PKB inhibitor epistasis and Foxo reporter assays","pmids":["18488031"],"confidence":"High","gaps":["How SLP-65 inhibits PI3K/PKB mechanistically not fully resolved","Relative contributions of Foxo1 versus Foxo3a not distinguished"]},{"year":2009,"claim":"Discovery that the SLP-65/CIN85 complex is constitutively preassembled in resting B cells and is required for subsequent BCR-induced membrane translocation and signaling revealed that BLNK operates from a pre-organized signaling platform rather than being assembled de novo upon stimulation.","evidence":"Quantitative mass spectrometry interactome, FRAP live imaging, CIN85-deficient cell functional analysis","pmids":["21822214"],"confidence":"High","gaps":["Subcellular identity of the pre-formed complex compartment not defined","How BCR engagement triggers translocation of the preassembled complex unknown"]},{"year":2012,"claim":"Characterization of HPK1-mediated Thr152 phosphorylation leading to 14-3-3 binding and ubiquitin-proteasomal degradation of BLNK defined a negative feedback loop that terminates BCR signaling, answering how BLNK activity is extinguished.","evidence":"In vitro kinase assays, Thr152 mutagenesis, ubiquitination site mapping, HPK1-deficient B cell analysis","pmids":["22334673"],"confidence":"High","gaps":["Identity of the E3 ubiquitin ligase targeting BLNK not determined","Kinetics of degradation versus dephosphorylation not compared"]},{"year":2013,"claim":"Demonstrating that the PLCγ2 C2 domain docks to a phospho-SLP-65 site in a Ca²⁺-dependent manner established a feed-forward amplification loop: initial Ca²⁺ release reinforces PLCγ2 anchoring, while Ca²⁺ decline terminates the interaction regardless of sustained phosphorylation.","evidence":"C2 domain mutagenesis, Ca²⁺-regulated binding assays, functional reconstitution","pmids":["24166973"],"confidence":"High","gaps":["Whether the C2 domain interaction is the dominant mechanism of PLCγ2 signal termination not established","Structural basis of Ca²⁺-regulated docking not resolved"]},{"year":2014,"claim":"NMR characterization showed that the SLP-65 N-terminus undergoes a disorder-to-order transition upon binding non-charged vesicle lipids, localizing SLP-65 to intracellular vesicles in resting cells and resolving the pre-stimulation compartment of the signaling scaffold.","evidence":"NMR spectroscopy with lipid vesicles, live cell imaging, mutagenesis with functional reconstitution","pmids":["25140054"],"confidence":"High","gaps":["Specific lipid species mediating vesicular targeting not identified","How vesicle-to-plasma-membrane transfer occurs upon BCR engagement not resolved"]},{"year":2020,"claim":"Crystal structure of the BLNK pThr152 peptide bound to 14-3-3σ and biophysical characterization of cooperativity with AKT-mediated pSer285 provided the structural basis for the gatekeeper model of BLNK negative regulation.","evidence":"X-ray crystallography, fluorescence polarization, isothermal titration calorimetry","pmids":["33176192"],"confidence":"High","gaps":["Full-length BLNK structure in complex with 14-3-3 not determined","In vivo significance of pSer285 cooperativity not tested"]},{"year":2022,"claim":"Placing SLP-65 upstream of a RHOA–PTEN axis that counteracts PI3K in pre-B cells provided a second tumor-suppressive mechanism complementary to JAK3 inhibition, explaining how BLNK controls the PI3K–Foxo balance for light chain recombination.","evidence":"Conditional RhoA knockout mice, PTEN membrane translocation assays, reconstitution in RhoA-deficient cells","pmids":["35371049"],"confidence":"High","gaps":["Direct physical link between SLP-65 and RHOA activation not identified","Whether RHOA-PTEN and JAK3 inhibition act redundantly or synergistically in tumor suppression unknown"]},{"year":2024,"claim":"Thermodynamic dissection of SLP-65/CIN85 multivalent interactions demonstrated that 18 individual SH3–PRM contacts drive liquid–liquid phase separation at vesicles, providing a quantitative biophysical framework for how the preassembled signaling scaffold forms.","evidence":"Individual Kd measurements for all PRM/SH3 pairs, LASSI computational modeling of phase separation, designer-construct phase separation assays","pmids":["38463037"],"confidence":"High","gaps":["Whether phase separation is required for signaling or is a byproduct of multivalency not functionally tested","How BCR stimulation modulates condensate properties unknown"]},{"year":2024,"claim":"Extension of BLNK function beyond B cells to macrophages showed that Syk-phosphorylated BLNK disrupts Fyn–c-Cbl interaction to inhibit podosome formation and migration, revealing a broader innate immune role.","evidence":"Monocyte-specific conditional BLNK knockout mice, Co-IP, podosome and migration assays, Candida infection model","pmids":["39413134"],"confidence":"High","gaps":["Whether BLNK functions in other myeloid or non-hematopoietic cells in vivo remains open","Structural basis of BLNK–c-Cbl competition with Fyn not resolved"]},{"year":null,"claim":"Key unresolved questions include the full-length structure of BLNK, how BCR engagement triggers translocation of the vesicular SLP-65/CIN85 condensate to the plasma membrane, the identity of the E3 ligase mediating BLNK ubiquitination, and the relative contributions of JAK3 inhibition versus RHOA-PTEN activation to tumor suppression.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length BLNK structure available","Mechanism of condensate-to-membrane translocation undefined","E3 ubiquitin ligase for BLNK not identified","Functional integration of multiple tumor-suppressive mechanisms not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,5,6,7,11,15]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[18,29]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,10,16]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[26,28]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,2,3,4,9,13,19,34,35]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,6,7,9,14,15,22,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,4,12,19,34,35]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,18]}],"complexes":["SLP-65/CIN85 vesicular condensate","BCR signalosome"],"partners":["SYK","PLCG2","BTK","GRB2","CIN85","JAK3","HPK1","VAV3"],"other_free_text":[]},"mechanistic_narrative":"BLNK (also known as SLP-65/BASH) is a central scaffolding adaptor protein in B cell receptor (BCR) signaling that coordinates activation of multiple downstream effector pathways essential for B cell development, activation, and tumor suppression. Upon BCR engagement, BLNK is recruited to the plasma membrane via its SH2 domain binding to phospho-Tyr204 of Igα and is phosphorylated on multiple tyrosines by Syk, creating docking sites that nucleate a macromolecular signaling complex containing PLCγ2 (via SH2 and Ca²⁺-regulated C2 domain interactions), Btk (facilitating Syk-dependent Btk Tyr551 phosphorylation), Vav/Grb2 (directing Rac1 activation at membrane rafts), H-Ras (sustaining ERK signaling), and HPK1 (mediating negative feedback through Thr152 phosphorylation, 14-3-3 binding, and ubiquitin-proteasomal degradation of BLNK) [PMID:9697839, PMID:10438904, PMID:11226282, PMID:12818159, PMID:19218240, PMID:22334673, PMID:24166973]. BLNK preassembles with CIN85 as a phase-separated condensate on intracellular vesicles in resting B cells through multivalent proline-rich motif–SH3 domain interactions, and its N-terminal lipid-binding module directs vesicular localization that is prerequisite for signal transduction [PMID:25140054, PMID:21822214, PMID:38463037]. Loss-of-function mutations in human BLNK cause agammaglobulinemia with a block at the pro-B to pre-B cell transition, and BLNK acts as a tumor suppressor in pre-B cells by directly inhibiting JAK3/STAT5 signaling and activating the RHOA–PTEN axis to counteract PI3K, thereby promoting Foxo-dependent immunoglobulin light chain recombination and limiting leukemogenic proliferation [PMID:10583958, PMID:12436112, PMID:19047679, PMID:18488031, PMID:35371049]. Beyond B cells, Syk-phosphorylated BLNK in macrophages competitively disrupts the Fyn–c-Cbl interaction to inhibit podosome formation and migration [PMID:39413134]."},"prefetch_data":{"uniprot":{"accession":"Q8WV28","full_name":"B-cell linker protein","aliases":["B-cell adapter containing a SH2 domain protein","B-cell adapter containing a Src homology 2 domain protein","Cytoplasmic adapter protein","Src homology 2 domain-containing leukocyte protein of 65 kDa","SLP-65"],"length_aa":456,"mass_kda":50.5,"function":"Functions as a central linker protein, downstream of the B-cell receptor (BCR), bridging the SYK kinase to a multitude of signaling pathways and regulating biological outcomes of B-cell function and development. Plays a role in the activation of ERK/EPHB2, MAP kinase p38 and JNK. Modulates AP1 activation. Important for the activation of NF-kappa-B and NFAT. Plays an important role in BCR-mediated PLCG1 and PLCG2 activation and Ca(2+) mobilization and is required for trafficking of the BCR to late endosomes. However, does not seem to be required for pre-BCR-mediated activation of MAP kinase and phosphatidyl-inositol 3 (PI3) kinase signaling. May be required for the RAC1-JNK pathway. Plays a critical role in orchestrating the pro-B cell to pre-B cell transition. May play an important role in BCR-induced B-cell apoptosis","subcellular_location":"Cytoplasm; Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q8WV28/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BLNK","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BLNK","total_profiled":1310},"omim":[{"mim_id":"614406","title":"SLP ADAPTOR- AND CSK-INTERACTING MEMBRANE PROTEIN; SCIMP","url":"https://www.omim.org/entry/614406"},{"mim_id":"613502","title":"AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4","url":"https://www.omim.org/entry/613502"},{"mim_id":"611434","title":"CYTOKINE-DEPENDENT HEMATOPOIETIC CELL LINKER; CLNK","url":"https://www.omim.org/entry/611434"},{"mim_id":"605719","title":"LINKER FOR ACTIVATION OF T CELLS FAMILY, MEMBER 2; LAT2","url":"https://www.omim.org/entry/605719"},{"mim_id":"604515","title":"B-CELL LINKER PROTEIN; BLNK","url":"https://www.omim.org/entry/604515"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":52.9}],"url":"https://www.proteinatlas.org/search/BLNK"},"hgnc":{"alias_symbol":["SLP65","Ly57","SLP-65","BLNK-s","BASH","bca"],"prev_symbol":[]},"alphafold":{"accession":"Q8WV28","domains":[{"cath_id":"3.30.505.10","chopping":"336-453","consensus_level":"high","plddt":93.4116,"start":336,"end":453}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WV28","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WV28-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WV28-F1-predicted_aligned_error_v6.png","plddt_mean":63.72},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BLNK","jax_strain_url":"https://www.jax.org/strain/search?query=BLNK"},"sequence":{"accession":"Q8WV28","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WV28.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WV28/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WV28"}},"corpus_meta":[{"pmid":"9697839","id":"PMC_9697839","title":"BLNK: a central linker protein in B cell activation.","date":"1998","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9697839","citation_count":424,"is_preprint":false},{"pmid":"10023776","id":"PMC_10023776","title":"BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10023776","citation_count":266,"is_preprint":false},{"pmid":"10591180","id":"PMC_10591180","title":"Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10591180","citation_count":242,"is_preprint":false},{"pmid":"10583958","id":"PMC_10583958","title":"An essential role for BLNK in human B cell development.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10583958","citation_count":236,"is_preprint":false},{"pmid":"10583957","id":"PMC_10583957","title":"Requirement for B cell linker protein (BLNK) in B cell development.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10583957","citation_count":224,"is_preprint":false},{"pmid":"16493428","id":"PMC_16493428","title":"SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond.","date":"2006","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16493428","citation_count":221,"is_preprint":false},{"pmid":"9705962","id":"PMC_9705962","title":"SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9705962","citation_count":216,"is_preprint":false},{"pmid":"10498607","id":"PMC_10498607","title":"Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10498607","citation_count":159,"is_preprint":false},{"pmid":"12436112","id":"PMC_12436112","title":"The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion.","date":"2002","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12436112","citation_count":142,"is_preprint":false},{"pmid":"18488031","id":"PMC_18488031","title":"SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway.","date":"2008","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18488031","citation_count":128,"is_preprint":false},{"pmid":"12387741","id":"PMC_12387741","title":"Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12387741","citation_count":121,"is_preprint":false},{"pmid":"9834055","id":"PMC_9834055","title":"BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9834055","citation_count":117,"is_preprint":false},{"pmid":"11226282","id":"PMC_11226282","title":"BLNK mediates Syk-dependent Btk activation.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11226282","citation_count":112,"is_preprint":false},{"pmid":"10700474","id":"PMC_10700474","title":"B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice.","date":"2000","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10700474","citation_count":110,"is_preprint":false},{"pmid":"11449366","id":"PMC_11449366","title":"Association of SLP-65/BLNK with the B cell antigen receptor through a non-ITAM tyrosine of Ig-alpha.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11449366","citation_count":106,"is_preprint":false},{"pmid":"12761551","id":"PMC_12761551","title":"Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12761551","citation_count":105,"is_preprint":false},{"pmid":"10688901","id":"PMC_10688901","title":"The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10688901","citation_count":105,"is_preprint":false},{"pmid":"19155498","id":"PMC_19155498","title":"B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19155498","citation_count":103,"is_preprint":false},{"pmid":"19047679","id":"PMC_19047679","title":"BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19047679","citation_count":99,"is_preprint":false},{"pmid":"11909947","id":"PMC_11909947","title":"The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11909947","citation_count":92,"is_preprint":false},{"pmid":"12456653","id":"PMC_12456653","title":"BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12456653","citation_count":92,"is_preprint":false},{"pmid":"18022864","id":"PMC_18022864","title":"CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18022864","citation_count":84,"is_preprint":false},{"pmid":"12835482","id":"PMC_12835482","title":"Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells.","date":"2003","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12835482","citation_count":83,"is_preprint":false},{"pmid":"11274146","id":"PMC_11274146","title":"The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11274146","citation_count":82,"is_preprint":false},{"pmid":"9857187","id":"PMC_9857187","title":"Induction of the antigen receptor expression on B lymphocytes results in rapid competence for signaling of SLP-65 and Syk.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9857187","citation_count":66,"is_preprint":false},{"pmid":"10438904","id":"PMC_10438904","title":"Cutting edge: association of phospholipase C-gamma 2 Src homology 2 domains with BLNK is critical for B cell antigen receptor signaling.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10438904","citation_count":63,"is_preprint":false},{"pmid":"21822214","id":"PMC_21822214","title":"The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21822214","citation_count":59,"is_preprint":false},{"pmid":"11449370","id":"PMC_11449370","title":"The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11449370","citation_count":53,"is_preprint":false},{"pmid":"22334673","id":"PMC_22334673","title":"Down-regulation of B cell receptor signaling by hematopoietic progenitor kinase 1 (HPK1)-mediated phosphorylation and ubiquitination of activated B cell linker protein (BLNK).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22334673","citation_count":52,"is_preprint":false},{"pmid":"11514608","id":"PMC_11514608","title":"B cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1.","date":"2001","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11514608","citation_count":51,"is_preprint":false},{"pmid":"12818159","id":"PMC_12818159","title":"Regulation of Vav localization in membrane rafts by adaptor molecules Grb2 and BLNK.","date":"2003","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12818159","citation_count":50,"is_preprint":false},{"pmid":"11489945","id":"PMC_11489945","title":"Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.","date":"2001","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11489945","citation_count":48,"is_preprint":false},{"pmid":"11680012","id":"PMC_11680012","title":"Mechanisms of signaling by the hematopoietic-specific adaptor proteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65.","date":"2001","source":"Advances in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11680012","citation_count":48,"is_preprint":false},{"pmid":"10677525","id":"PMC_10677525","title":"Adapter proteins SLP-76 and BLNK both are expressed by murine macrophages and are linked to signaling via Fcgamma receptors I and II/III.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10677525","citation_count":44,"is_preprint":false},{"pmid":"10744659","id":"PMC_10744659","title":"A BASH/SLP-76-related adaptor protein MIST/Clnk involved in IgE receptor-mediated mast cell degranulation.","date":"2000","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10744659","citation_count":40,"is_preprint":false},{"pmid":"15654340","id":"PMC_15654340","title":"A leucine zipper in the N terminus confers membrane association to SLP-65.","date":"2005","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15654340","citation_count":37,"is_preprint":false},{"pmid":"10820378","id":"PMC_10820378","title":"BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10820378","citation_count":31,"is_preprint":false},{"pmid":"10934198","id":"PMC_10934198","title":"Functional complementation of BLNK by SLP-76 and LAT linker proteins.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10934198","citation_count":30,"is_preprint":false},{"pmid":"14635051","id":"PMC_14635051","title":"B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.","date":"2003","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14635051","citation_count":29,"is_preprint":false},{"pmid":"24582315","id":"PMC_24582315","title":"The BLNK adaptor protein has a nonredundant role in human B-cell differentiation.","date":"2014","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24582315","citation_count":28,"is_preprint":false},{"pmid":"22363743","id":"PMC_22363743","title":"Identification of CMTM7 as a transmembrane linker of BLNK and the B-cell receptor.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22363743","citation_count":28,"is_preprint":false},{"pmid":"16585544","id":"PMC_16585544","title":"Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16585544","citation_count":27,"is_preprint":false},{"pmid":"19372136","id":"PMC_19372136","title":"SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins.","date":"2009","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/19372136","citation_count":26,"is_preprint":false},{"pmid":"15087455","id":"PMC_15087455","title":"Identification and characterization of a novel BASH N terminus-associated protein, BNAS2.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15087455","citation_count":24,"is_preprint":false},{"pmid":"15270728","id":"PMC_15270728","title":"Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells.","date":"2004","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15270728","citation_count":23,"is_preprint":false},{"pmid":"28130399","id":"PMC_28130399","title":"Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.","date":"2017","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/28130399","citation_count":22,"is_preprint":false},{"pmid":"19218240","id":"PMC_19218240","title":"BLNK binds active H-Ras to promote B cell receptor-mediated capping and ERK activation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19218240","citation_count":21,"is_preprint":false},{"pmid":"15528332","id":"PMC_15528332","title":"Impaired receptor editing in the primary B cell repertoire of BASH-deficient mice.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15528332","citation_count":19,"is_preprint":false},{"pmid":"16300960","id":"PMC_16300960","title":"Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells.","date":"2005","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16300960","citation_count":19,"is_preprint":false},{"pmid":"15029213","id":"PMC_15029213","title":"Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia.","date":"2004","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/15029213","citation_count":19,"is_preprint":false},{"pmid":"26703467","id":"PMC_26703467","title":"B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26703467","citation_count":19,"is_preprint":false},{"pmid":"36353208","id":"PMC_36353208","title":"Curcumin alleviates experimental colitis via a potential mechanism involving memory B cells and Bcl-6-Syk-BLNK signaling.","date":"2022","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/36353208","citation_count":18,"is_preprint":false},{"pmid":"32585766","id":"PMC_32585766","title":"Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma.","date":"2020","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32585766","citation_count":18,"is_preprint":false},{"pmid":"18245482","id":"PMC_18245482","title":"Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18245482","citation_count":18,"is_preprint":false},{"pmid":"16912232","id":"PMC_16912232","title":"Human SLP-65 isoforms contribute differently to activation and apoptosis of B lymphocytes.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16912232","citation_count":16,"is_preprint":false},{"pmid":"25140054","id":"PMC_25140054","title":"Macromolecular assembly of the adaptor SLP-65 at intracellular vesicles in resting B cells.","date":"2014","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25140054","citation_count":16,"is_preprint":false},{"pmid":"11240141","id":"PMC_11240141","title":"Hematopoietic cell-specific adapter proteins, SLP-76 and BLNK, effectively activate NF-AT as well as NF-kappaB by Syk and Tec PTKs in non-lymphoid cell lines.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11240141","citation_count":16,"is_preprint":false},{"pmid":"34653294","id":"PMC_34653294","title":"C/EBPβ induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutations.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/34653294","citation_count":15,"is_preprint":false},{"pmid":"27126461","id":"PMC_27126461","title":"Identification and characterisation of the immune response properties of Lampetra japonica BLNK.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27126461","citation_count":15,"is_preprint":false},{"pmid":"11813980","id":"PMC_11813980","title":"Role of BLNK in oxidative stress signaling in B cells.","date":"2001","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/11813980","citation_count":15,"is_preprint":false},{"pmid":"25893637","id":"PMC_25893637","title":"Enteroviral Infection in a Patient with BLNK Adaptor Protein Deficiency.","date":"2015","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25893637","citation_count":15,"is_preprint":false},{"pmid":"17681949","id":"PMC_17681949","title":"SLP-65 signal transduction requires Src homology 2 domain-mediated membrane anchoring and a kinase-independent adaptor function of Syk.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17681949","citation_count":15,"is_preprint":false},{"pmid":"33176192","id":"PMC_33176192","title":"A biophysical and structural analysis of the interaction of BLNK with 14-3-3 proteins.","date":"2020","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/33176192","citation_count":14,"is_preprint":false},{"pmid":"20008789","id":"PMC_20008789","title":"Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20008789","citation_count":13,"is_preprint":false},{"pmid":"16636677","id":"PMC_16636677","title":"SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16636677","citation_count":12,"is_preprint":false},{"pmid":"16568084","id":"PMC_16568084","title":"The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16568084","citation_count":12,"is_preprint":false},{"pmid":"16794253","id":"PMC_16794253","title":"BASH-novel PKC-Raf-1 pathway of pre-BCR signaling induces kappa gene rearrangement.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16794253","citation_count":11,"is_preprint":false},{"pmid":"15237108","id":"PMC_15237108","title":"BASH-deficient mice: limited primary repertoire and antibody formation, but sufficient affinity maturation and memory B cell generation, in anti-NP response.","date":"2004","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15237108","citation_count":10,"is_preprint":false},{"pmid":"14694181","id":"PMC_14694181","title":"Macrophage activation and Fcgamma receptor-mediated signaling do not require expression of the SLP-76 and SLP-65 adaptors.","date":"2003","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/14694181","citation_count":10,"is_preprint":false},{"pmid":"33416167","id":"PMC_33416167","title":"Involvement of Blnk and Foxo1 in tumor suppression in BCR‑ABL1‑transformed pro‑B cells.","date":"2020","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/33416167","citation_count":9,"is_preprint":false},{"pmid":"35933456","id":"PMC_35933456","title":"ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35933456","citation_count":9,"is_preprint":false},{"pmid":"24166973","id":"PMC_24166973","title":"Cutting edge: feed-forward activation of phospholipase Cγ2 via C2 domain-mediated binding to SLP65.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24166973","citation_count":8,"is_preprint":false},{"pmid":"16585562","id":"PMC_16585562","title":"Phospholipase Cgamma2 dosage is critical for B cell development in the absence of adaptor protein BLNK.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16585562","citation_count":8,"is_preprint":false},{"pmid":"29144032","id":"PMC_29144032","title":"MicroRNA-106b overexpression alleviates inflammation injury of cardiac endothelial cells by targeting BLNK via the NF-κB signaling pathway.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29144032","citation_count":8,"is_preprint":false},{"pmid":"30055251","id":"PMC_30055251","title":"Identification and functional analysis of grouper (Epinephelus coioides) B-cell linker protein BLNK.","date":"2018","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30055251","citation_count":8,"is_preprint":false},{"pmid":"36388990","id":"PMC_36388990","title":"B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/36388990","citation_count":7,"is_preprint":false},{"pmid":"39625751","id":"PMC_39625751","title":"RNA tertiary structure and conformational dynamics revealed by BASH MaP.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/39625751","citation_count":6,"is_preprint":false},{"pmid":"34521030","id":"PMC_34521030","title":"Silencing BLNK protects against interleukin-1β-induced chondrocyte injury through the NF-κB signaling pathway.","date":"2021","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/34521030","citation_count":6,"is_preprint":false},{"pmid":"39413134","id":"PMC_39413134","title":"BLNK negatively regulates innate antifungal immunity through inhibiting c-Cbl-mediated macrophage migration.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/39413134","citation_count":5,"is_preprint":false},{"pmid":"33617368","id":"PMC_33617368","title":"Genomic DNA methylation analysis reveals that BLNK is a key potential gene in the regulation of autophagy-related thyroid cancer progression.","date":"2021","source":"Genome","url":"https://pubmed.ncbi.nlm.nih.gov/33617368","citation_count":5,"is_preprint":false},{"pmid":"23066158","id":"PMC_23066158","title":"Highly restricted usage of Ig H chain VH14 family gene segments in Slp65-deficient pre-B cell leukemia in mice.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23066158","citation_count":4,"is_preprint":false},{"pmid":"38463037","id":"PMC_38463037","title":"Quantitative description of the phase-separation behavior of the multivalent SLP65-CIN85 complex.","date":"2024","source":"PNAS nexus","url":"https://pubmed.ncbi.nlm.nih.gov/38463037","citation_count":4,"is_preprint":false},{"pmid":"16760574","id":"PMC_16760574","title":"Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia.","date":"2006","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/16760574","citation_count":4,"is_preprint":false},{"pmid":"10397162","id":"PMC_10397162","title":"Characterization of the B cell-specific adaptor SLP-65 and other protein tyrosine kinase substrates by two-dimensional gel electrophoresis.","date":"1999","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/10397162","citation_count":4,"is_preprint":false},{"pmid":"35742868","id":"PMC_35742868","title":"The RelB-BLNK Axis Determines Cellular Response to a Novel Redox-Active Agent Betamethasone during Radiation Therapy in Prostate Cancer.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35742868","citation_count":3,"is_preprint":false},{"pmid":"32194234","id":"PMC_32194234","title":"Further delineation of primary B cell immunodeficiency caused by novel variants of the BLNK gene in two Chinese patients.","date":"2020","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/32194234","citation_count":3,"is_preprint":false},{"pmid":"35371049","id":"PMC_35371049","title":"The Small GTPase RHOA Links SLP65 Activation to PTEN Function in Pre B Cells and Is Essential for the Generation and Survival of Normal and Malignant B Cells.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35371049","citation_count":3,"is_preprint":false},{"pmid":"38411943","id":"PMC_38411943","title":"Circ_BLNK is a Unique Molecular Marker in Non-small Cell Lung Cancer.","date":"2024","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38411943","citation_count":2,"is_preprint":false},{"pmid":"41003929","id":"PMC_41003929","title":"Expression and regulation network of BLNK in CP/CPPS in animal, cell model and clinical samples.","date":"2025","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/41003929","citation_count":2,"is_preprint":false},{"pmid":"32512043","id":"PMC_32512043","title":"Lamprey VLRB participates in pathogen detection, VLRB/L-BLNK/L-NF-κB (B-like cells) signal transduction, and development.","date":"2020","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32512043","citation_count":2,"is_preprint":false},{"pmid":"16481341","id":"PMC_16481341","title":"The BASH/BLNK/SLP-65-associated protein BNAS1 regulates antigen-receptor signal transmission in B cells.","date":"2006","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16481341","citation_count":2,"is_preprint":false},{"pmid":"38686136","id":"PMC_38686136","title":"Nextflow vs. plain bash: different approaches to the parallelization of SNP calling from the whole genome sequence data.","date":"2024","source":"NAR genomics and bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/38686136","citation_count":2,"is_preprint":false},{"pmid":"36465938","id":"PMC_36465938","title":"BLNK mutation associated with T-cell LGL leukemia and autoimmune diseases: Case report in hematology.","date":"2022","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36465938","citation_count":2,"is_preprint":false},{"pmid":"38645201","id":"PMC_38645201","title":"RNA tertiary structure and conformational dynamics revealed by BASH MaP.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38645201","citation_count":1,"is_preprint":false},{"pmid":"21030983","id":"PMC_21030983","title":"Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.","date":"2010","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/21030983","citation_count":1,"is_preprint":false},{"pmid":"39041911","id":"PMC_39041911","title":"Cloud-based introduction to BASH programming for biologists.","date":"2024","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/39041911","citation_count":1,"is_preprint":false},{"pmid":"40403937","id":"PMC_40403937","title":"SLP65/SLP76 Csk-interacting membrane protein promotes hepatic ischemia-reperfusion injury by activating TLR4/Erk1/2-mediated macrophages M1 polarization.","date":"2025","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/40403937","citation_count":0,"is_preprint":false},{"pmid":"16481047","id":"PMC_16481047","title":"Double knockout mice show BASH and PKCdelta have different epistatic relationships in B cell maturation and CD40-mediated activation.","date":"2006","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/16481047","citation_count":0,"is_preprint":false},{"pmid":"35719418","id":"PMC_35719418","title":"A Novel BLNK Gene Mutation in a Four-Year-Old Child Who Presented with Late Onset of Severe Infections and High IgM Levels and Diagnosed and Followed as X-Linked Agammaglobulinemia for Two Years.","date":"2022","source":"Case reports in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35719418","citation_count":0,"is_preprint":false},{"pmid":"40546005","id":"PMC_40546005","title":"A Novel Homozygous CGA > TGA Mutation at Codon 123 (Exon 6) of B-Linker Protein (BLNK) as a Potential Cause of ‎Hepatopathy and Rickets: A Case Report.","date":"2025","source":"Iranian journal of immunology : IJI","url":"https://pubmed.ncbi.nlm.nih.gov/40546005","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46854,"output_tokens":8278,"usd":0.132366},"stage2":{"model":"claude-opus-4-6","input_tokens":12180,"output_tokens":4936,"usd":0.27645},"total_usd":0.408816,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"BLNK (B cell linker protein) was identified as a novel adaptor protein that interfaces the BCR-associated Syk tyrosine kinase with PLCγ, Vav guanine nucleotide exchange factor, and Grb2 and Nck adapter proteins. Tyrosine phosphorylation of BLNK by Syk provides docking sites for these SH2-containing effector molecules.\",\n      \"method\": \"Biochemical identification, Co-immunoprecipitation, tyrosine phosphorylation assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational discovery replicated across multiple labs, reciprocal Co-IP with multiple binding partners\",\n      \"pmids\": [\"9697839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"SLP-65/BLNK is a BCR signaling component that becomes tyrosine-phosphorylated upon BCR stimulation only when the BCR is expressed on the cell surface, and forms a signaling complex with Grb2 and Vav; phosphorylation requires BCR expression and is downstream of the BCR signaling subunit.\",\n      \"method\": \"Biochemical characterization, Co-immunoprecipitation, pervanadate stimulation assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — independently replicated, multiple orthogonal methods\",\n      \"pmids\": [\"9705962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"BLNK is required for BCR-induced PLCγ2 activation and JNK activation in B cells. The BCR-induced PLCγ2 activation (but not JNK activation) was restored by membrane-targeted PLCγ2 in BLNK-deficient B cells, indicating BLNK modulates PLCγ2 localization. JNK activation requires both Rac1 and PLCγ2, placing BLNK upstream of the Rac1-JNK pathway.\",\n      \"method\": \"Genetic reconstitution in BLNK-deficient DT40 B cells, membrane-targeted PLCγ2 rescue experiments\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — epistasis via reconstitution in BLNK-deficient cells with multiple pathway readouts\",\n      \"pmids\": [\"10023776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"BLNK is required in vivo for the pro-B to pre-B cell transition; BLNK-deficient mice are blocked at the B220+CD43+ progenitor B to B220+CD43- precursor B cell stage. BLNK links BCR-activated Syk kinase to the phosphoinositide and mitogen-activated kinase pathways.\",\n      \"method\": \"BLNK knockout mouse generation, flow cytometry of bone marrow B cell populations\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, independently replicated\",\n      \"pmids\": [\"10583957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Loss-of-function splice defect in human BLNK causes a block at the pro-B to pre-B cell transition, establishing an essential non-redundant role of BLNK in human B cell development.\",\n      \"method\": \"Patient genetic analysis, bone marrow immunophenotyping\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human loss-of-function with defined cellular phenotype, confirmed in multiple subsequent patients\",\n      \"pmids\": [\"10583958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"BLNK was identified as a major SH2 domain-binding protein of Bruton's tyrosine kinase (Btk); the interaction of BLNK with the SH2 domain of Btk contributes to complete tyrosine phosphorylation of PLCγ in BCR signaling.\",\n      \"method\": \"Protein purification, Co-immunoprecipitation, in vitro binding assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal pulldown and functional consequence demonstrated\",\n      \"pmids\": [\"10498607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The N-terminal SH2 domain of PLCγ2 mediates association with BLNK, and this interaction is required for inositol 1,4,5-trisphosphate generation upon BCR engagement; membrane-associated PLCγ2 with SH2(N) mutation still required BCR-CD16 co-ligation for activation, indicating BLNK directs PLCγ2 into proximity of the BCR signaling complex.\",\n      \"method\": \"Reconstitution in PLCγ2-deficient DT40 cells with SH2 domain mutants, IP3 generation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis plus functional reconstitution in defined-deficient cells\",\n      \"pmids\": [\"10438904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"BLNK mediates Syk-dependent Btk activation: BLNK allows Syk to phosphorylate Btk on tyrosine 551, enhancing Btk kinase activity. This requires the Btk-SH2 domain interaction with BLNK, and BCR-induced Btk phosphorylation and activation are significantly reduced in BLNK-deficient B cells.\",\n      \"method\": \"Reconstitution cell system, co-expression assays, phosphorylation analysis in BLNK-deficient cells, kinase activity assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution plus mutagenesis plus BLNK-deficient cell validation\",\n      \"pmids\": [\"11226282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"BLNK associates directly with the BCR signaling subunit Igα/Igβ heterodimer; this interaction is mediated by the SH2 domain of SLP-65 and the phosphorylated Igα tyrosine 204, which is located outside the ITAM, providing a mechanism for SLP-65 recruitment to the plasma membrane.\",\n      \"method\": \"Co-immunoprecipitation, direct binding assays with phospho-peptides, mutational analysis of Igα\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical interaction with defined binding sites confirmed by mutation\",\n      \"pmids\": [\"11449366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"BLNK is required for BCR-activated NF-κB activation, cell cycle entry (cyclin D2, CDK4 expression), and Bcl-xL upregulation. BLNK-deficient B cells show intact Akt and MAPK activation but impaired PLCγ2 and NF-κB activation, suggesting BLNK orchestrates a Btk-PLCγ2 signaling axis that regulates NF-κB.\",\n      \"method\": \"BLNK-knockout B cells, proliferation assays, Western blotting for cell cycle proteins and NF-κB pathway components\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple orthogonal pathway readouts\",\n      \"pmids\": [\"11274146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The non-ITAM tyrosines Y176 and Y204 of Igα are required for BLNK-dependent signaling pathways; BLNK binds directly to phospho-Y204 of Igα. Fusing BLNK to mutated Igα reconstituted downstream signaling, and BCR ligation induces Y204 phosphorylation and BLNK recruitment.\",\n      \"method\": \"Chimeric receptor reconstitution, mutational analysis of Igα, direct binding assays, Co-immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution with chimeric receptors plus mutagenesis and direct binding confirmation\",\n      \"pmids\": [\"11909947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Phosphorylation of five tyrosine residues within human BLNK nucleates distinct signaling effectors following BCR activation. Multiple tyrosine phosphorylations amplify PLCγ-mediated signaling and support 'cis'-mediated interaction between distinct signaling effectors within a large macromolecular complex.\",\n      \"method\": \"Mutagenesis of BLNK tyrosines, reconstitution in BLNK-deficient cells, biochemical analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with functional readouts\",\n      \"pmids\": [\"12456653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BLNK is a direct transcriptional target of Pax5 (BSAP); Pax5-dependent activation of BLNK expression is required for coupling Syk to downstream effector pathways during the pro-B to pre-B cell transition triggered by pre-BCR signaling.\",\n      \"method\": \"Genetic reconstitution of BLNK in Pax5-/- pro-B cells, inducible BLNK-ER fusion protein, gene expression analysis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via reconstitution with defined genetic models\",\n      \"pmids\": [\"12387741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SLP-65 (BLNK) acts as a tumor suppressor in pre-B cells: SLP-65-deficient pre-B cells show enhanced IL-7-dependent proliferative capacity and high incidence of pre-B lymphoma; reintroduction of SLP-65 led to pre-BCR downregulation and enhanced differentiation.\",\n      \"method\": \"SLP-65-/- mouse analysis, ex vivo proliferation assays, retroviral reconstitution\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO plus reconstitution with defined functional phenotypes\",\n      \"pmids\": [\"12436112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"BASH/BLNK SH2 domain interacts with hematopoietic progenitor kinase 1 (HPK1) upon BCR ligation through binding to phospho-Tyr379 of HPK1 (phosphorylated by Syk). This interaction activates HPK1 catalytically and subsequently activates IKKβ, defining a BCR signaling pathway from BASH to HPK1 to NF-κB.\",\n      \"method\": \"Co-immunoprecipitation, kinase activation assays, BASH- and Syk-deficient B cell analysis, mutational analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, deficient cell validation, phospho-site mutagenesis\",\n      \"pmids\": [\"11514608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BLNK and Grb2 cooperate to localize Vav3 into membrane rafts, which is required for efficient Rac1 activation upon BCR stimulation. Loss of either Grb2 or BLNK reduces Vav3 translocation to rafts; raft-targeted Vav3 restores defective Rac1 activation in Grb2- or BLNK-deficient cells.\",\n      \"method\": \"Membrane raft fractionation, epistasis via raft-targeted Vav3 rescue in BLNK/Grb2-deficient B cells\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis rescue experiment with multiple genetic models\",\n      \"pmids\": [\"12818159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A leucine zipper motif in the N-terminus of SLP-65 is responsible for its membrane association. Mutations in the N-terminus abolished SLP-65 membrane localization and activity; replacement with a myristoylation signal restored both. The N-terminus is a transferable autonomous domain that confers specific localization.\",\n      \"method\": \"Mutational analysis of SLP-65 N-terminus, GFP fusion localization, functional reconstitution in SLP-65-deficient cells\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with localization and functional readouts, domain transfer experiment\",\n      \"pmids\": [\"15654340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The C-terminal SH2 domain of SLP-65 controls efficient tyrosine phosphorylation by Syk, plasma membrane recruitment, and downstream signaling to NFAT. A kinase-independent adaptor function of Syk is required to link phosphorylated SLP-65 to Ca2+ mobilization, placing Syk both upstream and downstream of SLP-65.\",\n      \"method\": \"Mutational analysis in DT40 B cells; reconstitution of SLP-65 in SLP-76-deficient T cells; genetic epistasis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two genetic reconstitution systems with orthogonal readouts\",\n      \"pmids\": [\"17681949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BLNK suppresses pre-B cell leukemogenesis through direct physical binding to JAK3, inhibiting JAK3/STAT5 signaling and autocrine IL-7-driven proliferation. BLNK deficiency leads to constitutive JAK3/STAT5 activation; exogenous BLNK inhibited JAK3 activity dependent on the BLNK-JAK3 interaction.\",\n      \"method\": \"Co-immunoprecipitation, JAK3 kinase assays, JAK3 inhibitor treatment, STAT5-CA transgenic mouse, retroviral BLNK reconstitution in leukemia cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding demonstrated plus functional reconstitution with multiple readouts\",\n      \"pmids\": [\"19047679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SLP-65 counteracts PKB activation and promotes Foxo3a and Foxo1 activity in pre-B cells, thereby regulating light chain recombination. SLP-65-dependent signaling is linked to the PI(3)K-PKB-Foxo pathway, wherein PKB suppresses light chain recombination by phosphorylating Foxo proteins.\",\n      \"method\": \"Reconstitution of SLP-65 in deficient cells, epistasis with PKB inhibitors, Foxo reporter assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pathway epistasis with reconstitution and defined molecular intermediaries\",\n      \"pmids\": [\"18488031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The SLP-65/CIN85 complex is constitutively (stimulation-independently) associated in resting B cells. This pre-formed complex is required for SLP-65 phosphorylation and inducible plasma membrane translocation. In the absence of a SLP-65/CIN85 complex, BCR-induced Ca2+ and NF-κB responses are abrogated.\",\n      \"method\": \"Quantitative mass spectrometry interactome, live cell imaging (FRAP), Co-immunoprecipitation, CIN85-deficient cell analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-quantified interactome plus functional validation in deficient cells plus live imaging\",\n      \"pmids\": [\"21822214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mass spectrometry-based phosphoproteomics of SLP-65 revealed differential and dynamic engagement of numerous phospho-acceptor sites, including constitutive and BCR-induced phosphorylations. Serine 170 phosphorylation of SLP-65 acts as a BCR-distal checkpoint controlling some but not all B cell responses.\",\n      \"method\": \"Mass spectrometric phosphorylation mapping on DT40 cells, mutational analysis of phospho-sites with functional readouts\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — MS-based discovery with mutagenesis validation\",\n      \"pmids\": [\"19372136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BLNK binds the active (GTP-bound) form of H-Ras through a 10-amino acid Ras-binding domain. This interaction, facilitated by BCR cross-linking, is required for sustained ERK activation and BCR capping. The Ras-binding domain is necessary for restoring ERK activation and anti-apoptotic signaling in BLNK-deficient B cells.\",\n      \"method\": \"Pulldown assays, mutational analysis of BLNK Ras-binding domain, reconstitution in BLNK-deficient cells, BCR capping assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding domain mapped plus functional reconstitution\",\n      \"pmids\": [\"19218240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CMTM7, a tetra-spanning membrane protein, co-localizes with sIgM at the plasma membrane and links sIgM to BLNK. CMTM7 knockdown impairs BLNK-Syk interaction and BLNK phosphorylation. CMTM7 is constitutively associated with sIgM, and this is required for BLNK recruitment to sIgM.\",\n      \"method\": \"RNAi knockdown, Co-immunoprecipitation, mutational analysis of CMTM7 domains, functional rescue experiments\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — RNAi plus domain mutant rescue plus Co-IP\",\n      \"pmids\": [\"22363743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HPK1 phosphorylates BLNK at threonine 152, which mediates BLNK/14-3-3 binding. Thr152-phosphorylated BLNK is then ubiquitinated at lysines 37, 38, and 42, leading to BLNK degradation and attenuation of MAPK and IKK activation during BCR signaling (negative feedback).\",\n      \"method\": \"Kinase assays, site-directed mutagenesis, ubiquitination assays, HPK1-deficient B cell analysis, Co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — kinase assay plus mutagenesis of phospho-acceptor and ubiquitin sites plus deficient cell validation\",\n      \"pmids\": [\"22334673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The C2 domain of PLCγ2 docks in a Ca2+-regulated manner to a distinct phosphotyrosine of SLP-65, providing feed-forward signal amplification: early Ca2+ flux promotes anchoring of the PLCγ2 C2 domain to phospho-SLP65, and declining Ca2+ terminates PLCγ2 activation despite sustained SLP65 phosphorylation.\",\n      \"method\": \"Mutational analysis of PLCγ2 C2 domain, Ca2+-regulated binding assays, Co-immunoprecipitation, functional reconstitution\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis plus Ca2+-regulated binding plus functional reconstitution\",\n      \"pmids\": [\"24166973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SLP-65 assembles at intracellular vesicular compartments in resting B cells through an ~50 amino acid N-terminal module that binds non-charged lipid components of cellular membranes in a structurally ordered manner (disordered in solution). Pre-formed vesicular signaling scaffolds are required for BCR activation.\",\n      \"method\": \"NMR spectroscopy of SLP-65 N-terminus with membrane lipids, live cell imaging, fractionation, mutational analysis\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural characterization plus live imaging plus functional validation\",\n      \"pmids\": [\"25140054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The 14-3-3/BLNK interaction follows a gatekeeper model: HPK1-mediated phosphorylation of Thr152 (pT152) anchors BLNK to 14-3-3, and additional phosphorylation of Ser285 by AKT further improves affinity. Crystal structure of BLNKpT152 peptide bound to 14-3-3σ was solved.\",\n      \"method\": \"Fluorescent polarization, isothermal titration calorimetry, X-ray crystallography of BLNK peptide/14-3-3σ complex\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus biophysical characterization of the interaction\",\n      \"pmids\": [\"33176192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SLP65 and CIN85 form phase-separated condensates at intracellular vesicles in resting B cells via multivalent interactions (6 proline-rich motifs of SLP65 engaging 3 SH3 domains of CIN85, establishing 18 individual SH3-PRM interactions). Thermodynamic characterization of individual PRM/SH3 interactions allowed modeling of phase-separation behavior, and a previously unknown intramolecular interaction within the system was discovered.\",\n      \"method\": \"Biophysical measurement of individual dissociation constants, LASSI computational modeling, phase-separation assays with designer constructs\",\n      \"journal\": \"PNAS nexus\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — quantitative biophysical characterization of individual interactions plus validated computational modeling\",\n      \"pmids\": [\"38463037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In macrophages, CLR (C-type lectin receptor)-activated Syk phosphorylates BLNK, which then associates with c-Cbl and competitively inhibits the Fyn-c-Cbl interaction, disrupting c-Cbl-associated F-actin assembly and podosome ring formation, thereby impeding macrophage migration. BLNK deficiency in monocytes enhances migration and resistance to Candida albicans infection.\",\n      \"method\": \"Co-immunoprecipitation, monocyte-specific BLNK conditional KO mice, podosome assays, migration assays, murine infection model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined molecular mechanism plus in vivo infection model\",\n      \"pmids\": [\"39413134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In breast cancer cells, BLNK promotes anoikis (detachment-induced cell death) by activating p38 MAP kinase. ErbB2 blocks BLNK upregulation upon ECM detachment by reducing IRF6 transcription factor levels. Bortezomib upregulates IRF6 and BLNK, inhibiting 3D tumor growth in a BLNK-dependent manner.\",\n      \"method\": \"siRNA knockdown, anoikis assays, p38 kinase pathway analysis, IRF6 manipulation, xenograft tumor assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KD with defined pathway placement, but in non-lymphoid context without full reconstitution\",\n      \"pmids\": [\"35933456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BLNK interacts with Met receptor in non-small cell lung cancer cells, positively regulates Met signaling, and modulates ligand-dependent trafficking of Met. The BLNK-GRB2 constitutive interaction is increased in the presence of active Met, and Met-GRB2 interaction is increased in the presence of BLNK.\",\n      \"method\": \"Mammalian Membrane Two-Hybrid (MaMTH) interactome mapping, Co-immunoprecipitation, siRNA knockdown, trafficking and functional assays\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP pulldown plus functional KD but single study in non-lymphoid context\",\n      \"pmids\": [\"36388990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In CLL cells, BLNK participates in a CK2-CD5-BLNK-STAT3 complex that mediates constitutive serine 727 phosphorylation of STAT3. BLNK and CD5 are both required for STAT3 phosphorylation; siRNA knockdown of CD5 or BLNK significantly reduced pSTAT3 levels.\",\n      \"method\": \"Mass spectrometry identification of CK2 as STAT3 co-immunoprecipitant, in vitro CK2 kinase assay on STAT3, siRNA knockdown, fractionation studies, confocal microscopy\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — in vitro kinase assay plus Co-IP plus siRNA, but single lab and unusual cellular context\",\n      \"pmids\": [\"28130399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Neither SLP-76 nor LAT alone is sufficient to restore signaling deficits in BLNK-deficient B cells, but co-expression of SLP-76 and LAT together restores BCR-inducible calcium responses and activation of all three MAPK families, demonstrating functional complementation.\",\n      \"method\": \"Reconstitution of SLP-76 and LAT in BLNK-deficient B cells, Ca2+ flux assays, MAPK activation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via genetic reconstitution with multiple functional readouts\",\n      \"pmids\": [\"10934198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SLP-65 promotes B cell differentiation via a BASH-nPKC-Raf-1 pathway that induces kappa light chain gene rearrangement. Pre-BCR signaling through BASH activates novel PKC (nPKC) and MEK but not Ras; PKCη translocates to the plasma membrane upon BASH reconstitution.\",\n      \"method\": \"BASH-deficient pre-B cell lines, specific kinase inhibitors, retroviral transduction of active PKC/Raf-1, tamoxifen-inducible BASH reconstitution\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with inhibitors and genetic reconstitution identifying a Ras-independent signaling branch\",\n      \"pmids\": [\"16794253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SLP65 activates the small GTPase RHOA, which activates PTEN by enabling its translocation to the plasma membrane, thereby counteracting PI3K signaling in pre-B cells. Conditional RhoA-deficient mice show a complete block in early B cell development and fail to activate Ig gene rearrangement.\",\n      \"method\": \"Conditional RhoA knockout mice, PTEN membrane translocation assays, RhoA/Foxo1 reconstitution in RhoA-deficient cells, flow cytometric phenotyping\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with mechanistic reconstitution placing SLP65 upstream of RHOA-PTEN-PI3K axis\",\n      \"pmids\": [\"35371049\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BLNK/SLP-65 is a central scaffolding adaptor protein that is recruited to the BCR complex via direct binding of its SH2 domain to phospho-Tyr204 of Igα (facilitated by CMTM7), is phosphorylated on multiple tyrosines by Syk, and then nucleates a large signaling complex—preassembled as a phase-separated condensate with CIN85 at intracellular vesicles—that coordinates PLCγ2 activation (via SH2 and Ca2+-regulated C2 domain interactions), Btk activation (via Syk-mediated Tyr551 phosphorylation scaffolded by BLNK), Vav/Rac1 membrane raft targeting, H-Ras-ERK signaling, NF-κB activation, and Foxo-dependent light chain recombination, while being subject to negative feedback through HPK1-mediated Thr152 phosphorylation leading to 14-3-3 binding and ubiquitin-proteasomal degradation, and acting as a tumor suppressor in pre-B cells by directly inhibiting JAK3 and linking pre-BCR signals to RHOA-PTEN-mediated PI3K downregulation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BLNK (also known as SLP-65/BASH) is a central scaffolding adaptor protein in B cell receptor (BCR) signaling that coordinates activation of multiple downstream effector pathways essential for B cell development, activation, and tumor suppression. Upon BCR engagement, BLNK is recruited to the plasma membrane via its SH2 domain binding to phospho-Tyr204 of Igα and is phosphorylated on multiple tyrosines by Syk, creating docking sites that nucleate a macromolecular signaling complex containing PLCγ2 (via SH2 and Ca²⁺-regulated C2 domain interactions), Btk (facilitating Syk-dependent Btk Tyr551 phosphorylation), Vav/Grb2 (directing Rac1 activation at membrane rafts), H-Ras (sustaining ERK signaling), and HPK1 (mediating negative feedback through Thr152 phosphorylation, 14-3-3 binding, and ubiquitin-proteasomal degradation of BLNK) [PMID:9697839, PMID:10438904, PMID:11226282, PMID:12818159, PMID:19218240, PMID:22334673, PMID:24166973]. BLNK preassembles with CIN85 as a phase-separated condensate on intracellular vesicles in resting B cells through multivalent proline-rich motif–SH3 domain interactions, and its N-terminal lipid-binding module directs vesicular localization that is prerequisite for signal transduction [PMID:25140054, PMID:21822214, PMID:38463037]. Loss-of-function mutations in human BLNK cause agammaglobulinemia with a block at the pro-B to pre-B cell transition, and BLNK acts as a tumor suppressor in pre-B cells by directly inhibiting JAK3/STAT5 signaling and activating the RHOA–PTEN axis to counteract PI3K, thereby promoting Foxo-dependent immunoglobulin light chain recombination and limiting leukemogenic proliferation [PMID:10583958, PMID:12436112, PMID:19047679, PMID:18488031, PMID:35371049]. Beyond B cells, Syk-phosphorylated BLNK in macrophages competitively disrupts the Fyn–c-Cbl interaction to inhibit podosome formation and migration [PMID:39413134].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The identification of BLNK as a Syk substrate that docks PLCγ, Vav, Grb2, and Nck established that a single adaptor protein bridges BCR-proximal kinase signaling to multiple effector pathways, resolving how Syk communicates with diverse downstream targets.\",\n      \"evidence\": \"Biochemical purification, reciprocal Co-IP, and tyrosine phosphorylation mapping in B cell lines\",\n      \"pmids\": [\"9697839\", \"9705962\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphotyrosine–effector assignments not yet mapped\", \"In vivo requirement not yet tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Genetic studies in BLNK-knockout mice and a human patient with BLNK splice-site mutation demonstrated that BLNK is non-redundantly required for the pro-B to pre-B cell transition, establishing it as essential for early B cell development and a cause of human agammaglobulinemia.\",\n      \"evidence\": \"BLNK knockout mouse phenotyping by flow cytometry; human patient genetic and immunophenotypic analysis\",\n      \"pmids\": [\"10583957\", \"10583958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling events mediating the developmental block not yet dissected\", \"Whether BLNK has roles beyond early B cell development unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Reconstitution experiments in BLNK-deficient DT40 cells showed that BLNK controls PLCγ2 activation by directing its membrane localization and that BLNK scaffolds the Btk–PLCγ2 axis, resolving the mechanism by which the BCR activates phospholipase C.\",\n      \"evidence\": \"Membrane-targeted PLCγ2 rescue in BLNK-deficient DT40 cells; PLCγ2 SH2 domain mutagenesis; Btk-SH2/BLNK binding assays\",\n      \"pmids\": [\"10023776\", \"10438904\", \"10498607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PLCγ2 engagement involves additional regulatory domains beyond SH2 not yet known\", \"Stoichiometry of the BLNK–Btk–PLCγ2 complex undefined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapping of the BLNK–Igα interaction to phospho-Tyr204 (a non-ITAM tyrosine) via the BLNK SH2 domain resolved how BLNK is recruited to the BCR complex, establishing a mechanism distinct from classical ITAM-dependent signaling.\",\n      \"evidence\": \"Direct binding assays with phospho-peptides, Igα mutagenesis, chimeric receptor reconstitution\",\n      \"pmids\": [\"11449366\", \"11909947\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Tyr204 phosphorylation is itself regulated was unknown\", \"Whether additional BCR subunit contacts contribute to BLNK recruitment not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstration that BLNK scaffolds Syk-dependent phosphorylation of Btk at Tyr551 and that BLNK is required for NF-κB activation and cell cycle entry clarified that BLNK integrates BCR signals for both Ca²⁺ and NF-κB/survival pathways.\",\n      \"evidence\": \"Reconstitution/kinase assays in BLNK-deficient cells; NF-κB, cyclin D2, and Bcl-xL readouts in BLNK-KO B cells\",\n      \"pmids\": [\"11226282\", \"11274146\", \"11514608\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise mechanism linking BLNK to IKK activation via HPK1 not fully resolved\", \"Whether BLNK-independent NF-κB pathways compensate in vivo unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Systematic tyrosine mutagenesis of five BLNK phosphosites revealed that distinct phosphotyrosines nucleate different effector combinations, establishing a combinatorial phosphorylation code that amplifies PLCγ signaling through cis-interactions within a macromolecular complex.\",\n      \"evidence\": \"Individual and combinatorial Tyr-to-Phe mutagenesis with functional reconstitution in BLNK-deficient cells\",\n      \"pmids\": [\"12456653\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which kinase phosphorylates each individual tyrosine not fully determined\", \"Temporal order of phosphorylation events unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that SLP-65 deficiency leads to pre-B cell lymphoma and that its reintroduction restores differentiation established BLNK as a tumor suppressor, linking its signaling scaffold function to control of pre-B cell proliferation.\",\n      \"evidence\": \"SLP-65 knockout mouse tumor incidence, ex vivo proliferation assays, retroviral reconstitution\",\n      \"pmids\": [\"12436112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of tumor suppression not yet identified\", \"Whether tumor suppression is cell-autonomous not fully confirmed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing that BLNK and Grb2 cooperate to relocalize Vav3 into membrane rafts for Rac1 activation clarified how BLNK couples BCR signaling to cytoskeletal and JNK pathways through spatial control of a GEF.\",\n      \"evidence\": \"Raft fractionation and raft-targeted Vav3 rescue in BLNK- and Grb2-deficient DT40 cells\",\n      \"pmids\": [\"12818159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Vav1/Vav2 are similarly regulated by BLNK not tested\", \"In vivo relevance of raft targeting for B cell function not established\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of a leucine zipper-like N-terminal module as the autonomous membrane-targeting domain of SLP-65 resolved how this cytosolic adaptor achieves membrane association independently of BCR stimulation.\",\n      \"evidence\": \"N-terminal deletion/substitution mutagenesis with GFP localization and functional reconstitution in SLP-65-deficient cells\",\n      \"pmids\": [\"15654340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lipid specificity of the N-terminal module not yet defined\", \"Whether membrane targeting occurs at plasma membrane or intracellular vesicles not distinguished\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of direct BLNK–JAK3 binding and demonstration that BLNK inhibits JAK3/STAT5 signaling provided the molecular mechanism for BLNK's tumor suppressor function, explaining how its loss leads to constitutive proliferative signaling in pre-B cells.\",\n      \"evidence\": \"Co-IP, JAK3 kinase assays, JAK3 inhibitor treatment, and retroviral BLNK reconstitution in leukemia cells\",\n      \"pmids\": [\"19047679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of BLNK–JAK3 inhibition unknown\", \"Whether JAK3 inhibition is the sole tumor-suppressive mechanism not determined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linking SLP-65 to the PI3K–PKB–Foxo axis showed that BLNK counteracts PKB to promote Foxo-dependent light chain recombination, connecting the scaffold's signaling role to V(D)J recombination and B cell differentiation.\",\n      \"evidence\": \"SLP-65 reconstitution in deficient pre-B cells with PKB inhibitor epistasis and Foxo reporter assays\",\n      \"pmids\": [\"18488031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SLP-65 inhibits PI3K/PKB mechanistically not fully resolved\", \"Relative contributions of Foxo1 versus Foxo3a not distinguished\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that the SLP-65/CIN85 complex is constitutively preassembled in resting B cells and is required for subsequent BCR-induced membrane translocation and signaling revealed that BLNK operates from a pre-organized signaling platform rather than being assembled de novo upon stimulation.\",\n      \"evidence\": \"Quantitative mass spectrometry interactome, FRAP live imaging, CIN85-deficient cell functional analysis\",\n      \"pmids\": [\"21822214\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subcellular identity of the pre-formed complex compartment not defined\", \"How BCR engagement triggers translocation of the preassembled complex unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Characterization of HPK1-mediated Thr152 phosphorylation leading to 14-3-3 binding and ubiquitin-proteasomal degradation of BLNK defined a negative feedback loop that terminates BCR signaling, answering how BLNK activity is extinguished.\",\n      \"evidence\": \"In vitro kinase assays, Thr152 mutagenesis, ubiquitination site mapping, HPK1-deficient B cell analysis\",\n      \"pmids\": [\"22334673\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the E3 ubiquitin ligase targeting BLNK not determined\", \"Kinetics of degradation versus dephosphorylation not compared\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that the PLCγ2 C2 domain docks to a phospho-SLP-65 site in a Ca²⁺-dependent manner established a feed-forward amplification loop: initial Ca²⁺ release reinforces PLCγ2 anchoring, while Ca²⁺ decline terminates the interaction regardless of sustained phosphorylation.\",\n      \"evidence\": \"C2 domain mutagenesis, Ca²⁺-regulated binding assays, functional reconstitution\",\n      \"pmids\": [\"24166973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the C2 domain interaction is the dominant mechanism of PLCγ2 signal termination not established\", \"Structural basis of Ca²⁺-regulated docking not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"NMR characterization showed that the SLP-65 N-terminus undergoes a disorder-to-order transition upon binding non-charged vesicle lipids, localizing SLP-65 to intracellular vesicles in resting cells and resolving the pre-stimulation compartment of the signaling scaffold.\",\n      \"evidence\": \"NMR spectroscopy with lipid vesicles, live cell imaging, mutagenesis with functional reconstitution\",\n      \"pmids\": [\"25140054\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific lipid species mediating vesicular targeting not identified\", \"How vesicle-to-plasma-membrane transfer occurs upon BCR engagement not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Crystal structure of the BLNK pThr152 peptide bound to 14-3-3σ and biophysical characterization of cooperativity with AKT-mediated pSer285 provided the structural basis for the gatekeeper model of BLNK negative regulation.\",\n      \"evidence\": \"X-ray crystallography, fluorescence polarization, isothermal titration calorimetry\",\n      \"pmids\": [\"33176192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length BLNK structure in complex with 14-3-3 not determined\", \"In vivo significance of pSer285 cooperativity not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Placing SLP-65 upstream of a RHOA–PTEN axis that counteracts PI3K in pre-B cells provided a second tumor-suppressive mechanism complementary to JAK3 inhibition, explaining how BLNK controls the PI3K–Foxo balance for light chain recombination.\",\n      \"evidence\": \"Conditional RhoA knockout mice, PTEN membrane translocation assays, reconstitution in RhoA-deficient cells\",\n      \"pmids\": [\"35371049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical link between SLP-65 and RHOA activation not identified\", \"Whether RHOA-PTEN and JAK3 inhibition act redundantly or synergistically in tumor suppression unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Thermodynamic dissection of SLP-65/CIN85 multivalent interactions demonstrated that 18 individual SH3–PRM contacts drive liquid–liquid phase separation at vesicles, providing a quantitative biophysical framework for how the preassembled signaling scaffold forms.\",\n      \"evidence\": \"Individual Kd measurements for all PRM/SH3 pairs, LASSI computational modeling of phase separation, designer-construct phase separation assays\",\n      \"pmids\": [\"38463037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether phase separation is required for signaling or is a byproduct of multivalency not functionally tested\", \"How BCR stimulation modulates condensate properties unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extension of BLNK function beyond B cells to macrophages showed that Syk-phosphorylated BLNK disrupts Fyn–c-Cbl interaction to inhibit podosome formation and migration, revealing a broader innate immune role.\",\n      \"evidence\": \"Monocyte-specific conditional BLNK knockout mice, Co-IP, podosome and migration assays, Candida infection model\",\n      \"pmids\": [\"39413134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BLNK functions in other myeloid or non-hematopoietic cells in vivo remains open\", \"Structural basis of BLNK–c-Cbl competition with Fyn not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the full-length structure of BLNK, how BCR engagement triggers translocation of the vesicular SLP-65/CIN85 condensate to the plasma membrane, the identity of the E3 ligase mediating BLNK ubiquitination, and the relative contributions of JAK3 inhibition versus RHOA-PTEN activation to tumor suppression.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length BLNK structure available\", \"Mechanism of condensate-to-membrane translocation undefined\", \"E3 ubiquitin ligase for BLNK not identified\", \"Functional integration of multiple tumor-suppressive mechanisms not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 5, 6, 7, 11, 15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [18, 29]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 10, 16]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [26, 28]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 3, 4, 9, 13, 19, 34, 35]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 6, 7, 9, 14, 15, 22, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4, 12, 19, 34, 35]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 18]}\n    ],\n    \"complexes\": [\n      \"SLP-65/CIN85 vesicular condensate\",\n      \"BCR signalosome\"\n    ],\n    \"partners\": [\n      \"SYK\",\n      \"PLCG2\",\n      \"BTK\",\n      \"GRB2\",\n      \"CIN85\",\n      \"JAK3\",\n      \"HPK1\",\n      \"VAV3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}